House passes biotech funding bill

The US House of Representatives passed a linkurl:bill;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:h.r.05819: yesterday (Apr 23) that extends two programs providing federal grants to early-stage biotechs and other startups with promising ideas. The bill linkurl:reauthorizes;http://www.the-scientist.com/blog/display/54441/ both the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer Research (STTR) programs, which were due to sunset this year. The programs aim t

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The US House of Representatives passed a linkurl:bill;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:h.r.05819: yesterday (Apr 23) that extends two programs providing federal grants to early-stage biotechs and other startups with promising ideas. The bill linkurl:reauthorizes;http://www.the-scientist.com/blog/display/54441/ both the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer Research (STTR) programs, which were due to sunset this year. The programs aim to encourage the development and commercialization of products and technologies by small businesses, and the SBIR program granted more than $2 billion to start-ups last year. The legislation includes several enhancements to the SBIR program, for which some legislators and biotech advocates had been clamoring. First, it raises the award for a Phase I grant from $100,000 to $300,000 and ups Phase II awards from $750,000 to $2.2 million, which means more funding for high-tech, high-cost biomedical research. The bill also makes it easier for small businesses backed by venture capital to apply for awards, among other improvements. "In passing this legislation we will ensure that SBIR and STTR awards remain competitive, fund top-notch research, and continue producing cutting-edge breakthroughs," said Nydia Velazquez, Chairwoman of the House Small Business Committee, in a statement. "The bill recognizes that while many good ideas come from large companies and universities, it is American small businesses who are our primary source of innovation." The bill will now go to the Senate for consideration.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb